Showing results (131-140 of 236) with videos related to

Sort By:
Pageof 24
BMC Genomics|April 23, 2022
Comparison of SARS-CoV-2 sequencing using the ONT GridION and the Illumina MiSeqDerek Tshiabuila, Jennifer Giandhari, Sureshnee Pillay, et al.
Alimentary Pharmacology & Therapeutics|July 15, 1998
Nitric oxide and gall-bladder motor functionW Luman, J E Ardill, E Armstrong, et al.
Scientific Reports|September 8, 2021
Implementation of an efficient SARS-CoV-2 specimen pooling strategy for high throughput diagnostic testingLavanya Singh, Ugochukwu J Anyaneji, Wilfred Ndifon, et al.
Open Forum Infectious Diseases|April 10, 2026
Effect of the Scale-Up of Dolutegravir on Retention in Care, Risk of Developing Tuberculosis and Viral Load Suppression Among People Living With HIV: Analysis of Routine HIV Clinical Data in Rural KwaZulu-Natal, South Africa (2019-23)Reuben Christopher Moyo, Elphas Okango, Larisse Bolton, et al.
Plos One|April 26, 2023
Evaluation of miniaturized Illumina DNA preparation protocols for SARS-CoV-2 whole genome sequencingSureshnee Pillay, James Emmanuel San, Derek Tshiabuila, et al.
Leukemia & Lymphoma|November 17, 2006
The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trialP R A Taylor, J M White, R J Prescott, et al.
BMJ Global Health|April 9, 2025
Impact of increasing CD4 count threshold eligibility for antiretroviral therapy initiation on advanced HIV disease and tuberculosis prevalence and incidence in South Africa: an interrupted time series analysisKwabena Asare, Lara Lewis, Johan van der Molen, et al.
The Journal of Antimicrobial Chemotherapy|August 11, 2020
Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individualsBenjamin Chimukangara, Jennifer Giandhari, Richard Lessells, et al.
BMJ Open|February 17, 2021
Protocol for a randomised feasibility study of Point-Of-care HIV viral load testing to Enhance Re-suppression in South Africa: the POwER studyJienchi Dorward, Yukteshwar Sookrajh, Hope Ngobese, et al.
Viruses|September 23, 2022
Molecular Epidemiology and Trends in HIV-1 Transmitted Drug Resistance in Mozambique 1999-2018Nalia Ismael, Eduan Wilkinson, Isabel Mahumane, et al.
Pageof 24